Solid Tumor

Treatment stage
Short Name
Study Consent Form 
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?
Advanced Solid Tumors MYTHIC  

Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients with Advanced Solid Tumors


Kim Zola, RN 

Eligibility Criteria 
Advanced Solid Tumors MAGNETIC   Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination with Gemcitabine for the Treatment of Advanced Solid Tumors  NCT05147272 Kim Zola, RN Eligibility Criteria